88.12
price up icon8.67%   7.03
after-market アフターアワーズ: 88.77 0.65 +0.74%
loading
前日終値:
$81.09
開ける:
$81.3
24時間の取引高:
1.39M
Relative Volume:
0.75
時価総額:
$5.54B
収益:
当期純損益:
$-230.66M
株価収益率:
-21.11
EPS:
-4.1742
ネットキャッシュフロー:
$-148.12M
1週間 パフォーマンス:
-6.51%
1か月 パフォーマンス:
+167.11%
6か月 パフォーマンス:
+109.91%
1年 パフォーマンス:
+492.20%
1日の値動き範囲:
Value
$79.06
$88.50
1週間の範囲:
Value
$79.06
$103.27
52週間の値動き範囲:
Value
$12.64
$104.00

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
名前
Kodiak Sciences Inc
Name
セクター
Healthcare (1051)
Name
電話
650-281-0850
Name
住所
1250 PAGE MILL RD, PALO ALTO, CA
Name
職員
124
Name
Twitter
@kodiaksciences
Name
次回の収益日
2026-11-12
Name
最新のSEC提出書
Name
KOD's Discussions on Twitter

Compare KOD vs VRTX, MRNA, REGN, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
KOD icon
KOD
Kodiak Sciences Inc
88.12 5.54B 0 -230.66M -148.12M -4.1742
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
508.75 128.95B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
236.50 94.42B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
796.34 81.99B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
846.27 53.22B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
374.08 42.32B 5.76B 514.49M 1.10B 4.4813

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-24 再開されました Goldman Neutral
2026-05-11 アップグレード Chardan Capital Markets Neutral → Buy
2025-11-11 アップグレード H.C. Wainwright Neutral → Buy
2025-10-24 アップグレード JP Morgan Neutral → Overweight
2025-09-25 アップグレード Barclays Underweight → Equal Weight
2025-09-22 開始されました Jefferies Buy
2025-08-14 アップグレード JP Morgan Underweight → Neutral
2024-12-09 アップグレード Jefferies Hold → Buy
2024-09-05 開始されました H.C. Wainwright Neutral
2023-12-11 再開されました Goldman Sell
2023-11-17 アップグレード CapitalOne Equal Weight → Overweight
2023-07-27 ダウングレード UBS Buy → Neutral
2023-07-25 ダウングレード Chardan Capital Markets Buy → Neutral
2023-07-25 ダウングレード JP Morgan Neutral → Underweight
2023-07-24 ダウングレード CapitalOne Overweight → Equal Weight
2023-07-24 ダウングレード Jefferies Buy → Hold
2022-11-15 開始されました CapitalOne Overweight
2022-08-02 ダウングレード Citigroup Neutral → Sell
2022-02-24 ダウングレード JP Morgan Overweight → Neutral
2022-02-11 開始されました Goldman Buy
2022-02-02 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード ROTH Capital Neutral → Buy
2021-03-12 開始されました Evercore ISI Outperform
2021-03-01 ダウングレード Barclays Equal Weight → Underweight
2021-02-17 ダウングレード ROTH Capital Buy → Neutral
2021-01-25 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-12-17 開始されました Berenberg Buy
2020-12-16 開始されました UBS Buy
2020-12-11 開始されました Citigroup Neutral
2020-11-30 ダウングレード JP Morgan Overweight → Neutral
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-13 ダウングレード Goldman Buy → Neutral
2020-03-31 開始されました BMO Capital Markets Outperform
2020-03-03 開始されました Goldman Buy
2020-02-18 ダウングレード Barclays Overweight → Equal Weight
2020-02-06 開始されました SunTrust Buy
2020-01-08 開始されました ROTH Capital Buy
2020-01-03 開始されました Jefferies Buy
2019-12-24 開始されました JP Morgan Overweight
2019-10-15 繰り返されました Chardan Capital Markets Buy
2019-02-20 開始されました Chardan Capital Markets Buy
2018-10-29 開始されました Barclays Overweight
2018-10-29 開始されました BofA/Merrill Buy
2018-10-29 開始されました Morgan Stanley Overweight
すべてを表示

Kodiak Sciences Inc (KOD) 最新ニュース

pulisher
Oct 09, 2026

Kodiak Sciences Inc. (KOD) stock price, news, quote and history - Yahoo Finance Singapore

Oct 09, 2026
pulisher
Oct 01, 2026

Kodiak Sciences More Than Doubles on Eye Disease Trial Results - Barchart.com

Oct 01, 2026
pulisher
Oct 01, 2026

Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com South Africa

Oct 01, 2026
pulisher
Oct 01, 2026

Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com Nigeria

Oct 01, 2026
pulisher
Oct 01, 2026

Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com Canada

Oct 01, 2026
pulisher
Sep 30, 2026

Kodiak Sciences(KOD.US) 10% Shareholder Buys US$156.99 Million in Common Stock - Moomoo

Sep 30, 2026
pulisher
Sep 30, 2026

A stock acquisition changes beneficial ownership by more than 1% at Kodiak Sciences (KOD). - Stock Titan

Sep 30, 2026
pulisher
Sep 30, 2026

Baker Bros. Advisors Reports Multiple Open-Market Buys of Kodiak Sciences Stock - Kalkine Media

Sep 30, 2026
pulisher
Sep 30, 2026

In 30 transactions, Baker funds bought shares of Kodiak Sciences (KOD). - Stock Titan

Sep 30, 2026
pulisher
Sep 30, 2026

Funds buy Kodiak Sciences (KOD) shares at average prices of about $79–$86. - Stock Titan

Sep 30, 2026
pulisher
Sep 30, 2026

Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com Canada

Sep 30, 2026
pulisher
Sep 29, 2026

Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com South Africa

Sep 29, 2026
pulisher
Sep 29, 2026

Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026
pulisher
Sep 29, 2026

Options at $2.49 a share are among those Kodiak Sciences (KOD) CEO exercised. - Stock Titan

Sep 29, 2026
pulisher
Sep 29, 2026

Diluted net income available to common stockholders of Kodiak Sciences, Inc. – HAN:K27 - TradingView

Sep 29, 2026
pulisher
Sep 29, 2026

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 29, 2026

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - Stocktwits

Sep 29, 2026
pulisher
Sep 28, 2026

Kodiak Sciences Inc (NASDAQ: KOD) Share Price, KOD Stock News, KOD Share Price & Updates - Kalkine

Sep 28, 2026
pulisher
Sep 28, 2026

Form 8K Kodiak Sciences Inc For: 28 September By Investing.com - Investing.com Canada

Sep 28, 2026
pulisher
Sep 28, 2026

Form 8K Kodiak Sciences Inc For: 28 September By Investing.com - Investing.com India

Sep 28, 2026
pulisher
Sep 28, 2026

Both treatments met a year-one vision goal in Kodiak Sciences (KOD)'s eye disease trial. - Stock Titan

Sep 28, 2026
pulisher
Sep 28, 2026

Why Is Kodiak Sciences (NASDAQ:KOD) Suddenly a Must-Watch Healthcare Stocks Name? - Kalkine Media

Sep 28, 2026
pulisher
Sep 28, 2026

Kodiak Sciences (Nasdaq:KOD)Stock Analysis - Simply Wall Street

Sep 28, 2026
pulisher
Sep 28, 2026

Kodiak Stock Soars (Again) As Data Shows Long-Lasting Eye Meds Are The 'Real Deal' (KOD) - Seeking Alpha

Sep 28, 2026
pulisher
Sep 25, 2026

Kodiak Sciences to report phase 3 trial results Monday By Investing.com - Investing.com South Africa

Sep 25, 2026
pulisher
Sep 24, 2026

What DAYBREAK Trial Results Could Mean For Kodiak Sciences Stock - simplywall.st

Sep 24, 2026
pulisher
Sep 24, 2026

Goldman Sachs initiates Kodiak Sciences stock coverage with neutral rating - Investing.com

Sep 24, 2026
pulisher
Sep 23, 2026

The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte - Zacks Investment Research

Sep 23, 2026
pulisher
Sep 21, 2026

Kodiak Sciences (KOD) Pulls Back After A Strong Year, Is The Valuation Still Too Rich? - simplywall.st

Sep 21, 2026
pulisher
Sep 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook By Investing.com - Investing.com South Africa

Sep 17, 2026
pulisher
Sep 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook - Investing.com India

Sep 17, 2026
pulisher
Sep 16, 2026

After $435,870 sale, Gilead (NASDAQ: GILD) CFO still holds 164K shares - Stock Titan

Sep 16, 2026
pulisher
Sep 13, 2026

3 Small-Cap Biotechs With Binary Catalysts on the Calendar - marketbeat.com

Sep 13, 2026
pulisher
Sep 03, 2026

Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts - Yahoo Finance

Sep 03, 2026
pulisher
Sep 01, 2026

Kodiak Sciences (KOD): Three Phase 3 Readouts In SightWill The Data See It Through? - RTTNews

Sep 01, 2026
pulisher
Sep 01, 2026

Former Sight Sciences (NASDAQ: SGHT) officer lines up more share sales after a string of summer trades - Stock Titan

Sep 01, 2026
pulisher
Aug 27, 2026

Kodiak Sciences Inc (KOD) Peer Comparison – Compare with Others - valueresearchonline.com

Aug 27, 2026
pulisher
Aug 26, 2026

What Kodiak Sciences (KOD)'s Widening Net Losses and Lower H1 Loss Per Share Mean For Shareholders - simplywall.st

Aug 26, 2026
pulisher
Aug 24, 2026

BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants - Yahoo Finance

Aug 24, 2026
pulisher
Aug 21, 2026

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 4.1%Time to Sell? - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Kodiak Sciences enrolls first patients in phase 3 DME trial By Investing.com - Investing.com Nigeria

Aug 20, 2026
pulisher
Aug 19, 2026

HC Wainwright Lowers Earnings Estimates for Kodiak Sciences - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

GSA Capital Partners LLP Takes $1.07 Million Position in Kodiak Sciences Inc. $KOD - MarketBeat

Aug 18, 2026
pulisher
Aug 17, 2026

KOD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $58 - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com Nigeria

Aug 17, 2026
pulisher
Aug 17, 2026

HC Wainwright Reaffirms "Buy" Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy - Investing.com

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com India

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com UK

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy - Investing.com

Aug 17, 2026

Kodiak Sciences Inc (KOD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Kodiak Sciences Inc (KOD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BAKER BROS. ADVISORS LP
Director
Sep 29 '26
Buy
85.05
33,726
2,868,255
20,191,214
BAKER BROS. ADVISORS LP
Director
Sep 28 '26
Buy
83.58
418,323
34,963,077
19,515,907
BAKER BROS. ADVISORS LP
Director
Sep 28 '26
Buy
72.57
807,840
58,625,708
19,121,134
PERLROTH VICTOR
Chairman and CEO
Sep 25 '26
Option Exercise
4.20
1,280,524
5,381,943
3,676,062
BORGESON JOHN A.
Chief Financial Officer
Jun 04 '26
Sale
34.10
30,000
1,023,009
211,930
JOHN BORGESON
Officer
Jun 04 '26
Proposed Sale
33.87
30,000
1,016,100
0
BORGESON JOHN A.
Chief Financial Officer
Jun 04 '26
Option Exercise
1.04
30,000
31,200
241,930
BORGESON JOHN A.
Chief Financial Officer
Apr 15 '26
Option Exercise
1.04
28,614
29,759
211,930
JOHN BORGESON
Officer
Apr 02 '26
Proposed Sale
42.81
30,000
1,284,300
0
BORGESON JOHN A.
Chief Financial Officer
Apr 02 '26
Sale
39.92
30,000
1,197,488
183,316
$61.86
price up icon 0.03%
$27.51
price down icon 1.40%
$82.39
price up icon 3.04%
$14.87
price up icon 1.16%
$298.50
price up icon 1.19%
$29.51
price up icon 4.83%
大文字化:     |  ボリューム (24 時間):